Thyroid and androgen receptor signaling are antagonized by mu-Crystallin in prostate cancer

INTERNATIONAL JOURNAL OF CANCER

Aksoy, O; Pencik, J; Hartenbach, M; Moazzami, AA; Schlederer, M; Balber, T; Varady, A; Philippe, C; Baltzer, PA; Mazumder, B; Whitchurch, JB; Roberts, CJ; Haitel, A; Herac, M; Susani, M; Mitterhauser, M; Marculescu, R; Stangl-Kremser, J; Hassler, MR; Kramer, G; Shariat, SF; Turner, SD; Tichy, B; Oppelt, J; Pospisilova, S; Hartenbach, S; Tangermann, S; Egger, G; Neubauer, HA; Moriggl, R; Culig, Z; Greiner, G; Hoermann, G; Hacker, M; Heery, DM; Merkel, O; Kenner, L, 2021: Thyroid and androgen receptor signaling are antagonized by mu-Crystallin in prostate cancer. INTERNATIONAL JOURNAL OF CANCER 148(3), p. 731 - 747, doi: 10.1002/ijc.33332

Research Groups:

Medical Genomics

CEITEC authors:

Boris Tichý, Ph.D.
Prof. Šárka Pospíšilová, Ph.D.